Expansion of natural killer cells with lyticactivity against acute myeloid leukemia blasts under good manufacturing practice conditions. A possible new strategy for allografted patients?

被引：0
|
作者：
Torelli, G. F. [1 ]
机构：
[1] Univ Roma La Sapienza, Rome, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0593
引用
收藏
页码：220 / 221
页数：2
相关论文
共 13 条
  • [1] Natural killer cells expanded under good manufacturing practice conditions exert lytic activity against acute myeloid leukemia blasts
    Mascolo, M. G.
    Torelli, G. F.
    Ricciardi, M. R.
    De Propris, M. S.
    Milano, F.
    Lucarelli, B.
    Valle, V.
    Lannella, E.
    Arleo, E.
    Iori, A. P.
    Tafuri, A.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 95 - 96
  • [2] NATURAL KILLER CELL EXPANSION UNDER GOOD MANUFACTURING PRACTICE CONDITIONS FOR CLINICAL USE IN ADULT PHILADELPHIA plus ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
    Peragine, N.
    Torelli, G.
    Raponi, S.
    Rozera, C.
    Mariglia, P.
    Barberi, W.
    Vitale, A.
    Belardelli, F.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA, 2013, 98 : 413 - 413
  • [3] Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice
    U Siegler
    C P Kalberer
    P Nowbakht
    S Sendelov
    S Meyer-Monard
    A Wodnar-Filipowicz
    Leukemia, 2005, 19 : 2215 - 2222
  • [4] Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice
    Siegler, U
    Kalberer, CP
    Nowbakht, P
    Sendelov, S
    Meyer-Monard, S
    Wodnar-Filipowicz, A
    LEUKEMIA, 2005, 19 (12) : 2215 - 2222
  • [5] Natural killer cell production under good manufacturing practice conditions to treat cancer patients
    Perez-Martinez, A.
    Santamaria, S.
    Varela, M. A.
    Leivas, A.
    Valentin, J.
    Fernandez, L.
    Martinez, J.
    HUMAN GENE THERAPY, 2013, 24 (12) : A165 - A166
  • [6] In vitro expansion of human natural killer cells under good manufacturing practice conditions for multiple mega dose infusions as immunotherapy of haematopoietic malignancies
    Kalberer, C.
    Siegler, U.
    Stern, M.
    Passweg, J. R.
    Tichelli, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S311 - S311
  • [7] Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission
    Torelli, Giovanni F.
    Guarini, Anna
    Maggio, Roberta
    Alfieri, Cecilia
    Vitale, Antonella
    Foa, Robin
    HAEMATOLOGICA, 2005, 90 (06) : 785 - 792
  • [8] Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
    Siegler, Uwe
    Meyer-Monard, Sandrine
    Joerger, Simon
    Stern, Martin
    Tichelli, Andre
    Gratwohl, Alois
    Wodnar-Filipowicz, Aleksandra
    Kalberer, Christian P.
    CYTOTHERAPY, 2010, 12 (06) : 750 - 763
  • [9] Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
    Tam, YK
    Martinson, JA
    Doligosa, K
    Klingemann, HG
    CYTOTHERAPY, 2003, 5 (03) : 259 - 272
  • [10] IMMUNE THERAPY FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML): DEVELOPMENT OF A GOOD MANUFACTURING PRACTICE (GMP) CONFORM PROTOCOL BASED ON WILMS' TUMOR 1(WT1)-SPECIFIC CYTOTOXIC T CELLS (CTL)
    Hermann, Eugenie
    Horn, Peter A.
    Lindemann, Monika
    Ottinger, Hellmut
    Beelen, Dietrich W.
    Buttkereit, Ulrike
    ANNALS OF HEMATOLOGY, 2013, 92 : S14 - S15
12